The study was conducted in collaboration with the Centre for Healthy Brain Ageing (CHeBA) at the University of New South Wales and the University of Adelaide.
The results have been published in the Journal of American Geriatrics.
The trial involved a Study of Mental and Resistance Training (SMART) carried out on patients with mild cognitive impairment (MCI) between 55-68 years old. Patients with MCI have a higher risk of developing dementia and Alzheimer's disease.
The findings are particularly significant given the high incidence of dementia and Alzheimer's disease among the aging population. According to the 2016 World Alzheimer Report, 47 million people worldwide have dementia and this number is expected to triple by 2050.
In the United States, the figure predicted for people with Alzheimer's disease in 2050 is 13.8 million.
Due to the high cost of care for patients with dementia, the World Alzheimer Report recommends moving beyond specialist care. The report suggests a holistic approach that focuses on improving the quality of life for people living with the condition.
No comments:
Post a Comment